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During the course of large scale purification of the Dj dopaminc receptor from m t brain, a protein of~87,000 daltons (p87) was observed to ¢opurify 
with the D~ receptor through four chromatographic steps. To characterize the nature of this protein, bovine a d rat eDNA clones were isolated 
and sequenced. The bovine and rat clones were highly conserved (98.5% identity). Each clone possessed an open reading frame of 222fi base pairs 
encoding a protein of 742 amino acids (calculated MW of 82,500), containing three stretches of peptide sequence obtained from p87 sequence 
analysis. Comparison of the deduced peptide sequence of thisprotein ~vith those found in available databanks revealed that it was a novel protein 
related to the family of nutrient transport proteins from eakaryotes and bacteria, including, the mammalian facilitated glucose transporters, th'. 
yeast ransporters for maltose, lactose, andglucose, and the proton-driven bactcrial transporters for arabinose, xylose, and citrate, in addition p87 
al~o shares with these transporters a similar hydropathicity profile that sugg sts the presence of 12 transmcmbrane segments. The mRNA for pS7 
appears to be localized primarily, if not exclusively, to the central nervous sy tem. Northern blot analysis reveals a message of..-4.8 kb in cortex, 
hippoeampus, brain stem, and cerebellum, but no detectable signal i  peripheral tissues such as spleen, liver, kidney, lung, heart, or skeletal muscle. 
Evidence form Western blot analysis and immunohistechemistry suggests that this protein may be expressed in intracellular o ganelles or the 
membrane of synaptosomes rather than plasma membrane. Based on its structure and properties, p87 appears to define a new clas~ of transporter- 
like proteins. 
Transporter-like protein; Central nervous system; Molecular cloning; Protein characterization 
1. INTRODUCTION 
Given the complexity of the CNS, numerous methods 
have been developed to study its function. One avenue 
of research as been the identification and study of 
proteins which appear to be unique to the central nerv- 
ous system: proteins which have been estimated tocom- 
prise perhaps as many as two-thirds of the products 
encoded by the ~enome. This approach does not depend 
on a prior understanding of function, has proven to be 
enormously successful. For example, several new mem- 
bers of the family of G-protein coupled receptors [24] 
and transport proteins were cloned before their en- 
dogenous ligand or substrate was known. However, 
many of these 'orphan' receptors and transporters have 
now been identified including receptors for 5-HT 
(5-HTLA, 5-HTtD), cannabinol, and adenosine 
[12,18,25,27], and the Na + and Cl--dependent trans- 
porters for proline, serotonin, to list only a few exam- 
Correspondence address: J.A. Gingrieh, Howard Hughes Medical In- 
stitute Research Laboratories, Depts. of Cell Biology and Medicine, 
Duke University Medical Center, Durham, NC 27710, USA. 
*On sabbatical leave from: Thu Departn'~eat of Molecular Pharma- 
cology and Bioseienee, Novo Nordisk A/S Bagsvaerd, DK-2880, 
Denmark. 
pies [4,13]. Likewise, understanding of the mechanisms 
of synaptic vesicle function has advanced through the 
purification and characterization f their protein com- 
ponents without prior knowledge of their function 
[2,20,28,29,31]. The power of this approach eontinues 
to grow as the structure of more functional families of 
proteins are defined. 
It was the recent success of this reverse approach to 
understanding biochemical function which led us to 
characterize, p87, a protein of moleeuk.r weight 87,000 
Da which persistently copurified with the D~ receptor 
through four chromatographic steps including a ligand- 
based affinity chromatographic step based on the selec- 
tive antagonist SCH23,390. During this procedure, the 
Dj receptor was enriched more than 3,000-fold and p87 
was estimated to represent approximately 50% of the 
total protein. We reasoned that p87 could be of poten- 
tial interest first because of its potential ability to asso- 
ciate with the Di dopamine receptor or second because 
of the possibility that this protein might interact with 
benzazepine compounds such as SCH 23,390. 
In this report we describe the purification, cloning, 
and characterization of p87. The rat and bovine DNAs 
for this protein revealed significant homology of its de- 
duced sequence with a family of nutrient ransporter 
proteins which includes the mammalian glucose trans- 
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porter, and bacterial transporters for xylose, arabinose, 
citrate, lactose and tetracycline. Based on Northern and 
Western blot analysis, this protein was found to be lo- 
calized predominantly to the CNS. The predicted mem- 
brane topography of this transporter-like protein sug- 
gests that it represents he first member of a novel trans- 
porter-like family. Preliminary accounts of this work 
have previously been published in abstract form [13,16]. 
2, MATERIALS AND METHODS 
2. I. Put,cation of the Dt dopamlne receptor 
The Dj dopamine receptor was purified as described elsewhere 
(Gingrich etal., in preparation) with some modifications to accommo- 
date the iaereased scale. Briefly, approximately 2,000 rat brains were 
dissect~t to remove their striata in three batches. Each batch was 
solabilized and affinity-purified independently [14]. These ¢luates were 
pooled and concentrated onQ-Sepharose, and then chromatographed 
on two Superose 6 columns in tandem. The peak fractions were pooled 
and applied to a WGA agarose column and elated with N-aeetylgla- 
cosamine. From this procedure 417 pmol of ['~H]SCH23390 binding 
activity was recovered with a specific activity estimated at 6 nmol 
[~H]SCH23390 bound/rag protein, or about 50% pure. For analysis, 
a 1% aliquot of the purified receptor preparation was removed and 
radioiodinated with 0.2mCi [~=Sl]Bolton-Hunter reagent for 4 h at 4"C 
(Langstone, 1980). The samples were elecrophoresed on preparative 
SDS-PAGE, the bands localized by autoradiography, cutand electro- 
elated. The samples were then lyophilized (Savant Instruments) and 
resuspended in 70% formic acid containing 0.5 M CNBr in a polypro- 
pylen¢ Eppendorf tube. The reaction '¢,'.~ allowed to proceed 24 h in 
the dark ~,.t room temperature and then l),ophiiized. 
The samples were then resuspended in 0.175 ml of 0.1% tri- 
finoroacetic acid (TFA) in water (solution A), loaded on a 2.1 
mm x 100 mm C-8 column, and elated with a gradient of solution B 
(70% acetonitrile (Jackson/Burdiek), 29.9% water, 0. i % TFA) at 0.5% 
acetonitrilcmin (flow rate = 0.1 ml/min, 1 fraction/rain). Optical den- 
sity (O.D.) at 214 nm was monitored throughout the run. Fractions 
were spotted onto polybrene coated glass fiber filters and subjected to 
automated Edman degradation sequencing. 
2.2. LlbratT screenblg 
Oligonucleotid¢ probes were synthesized based on pcptide sequence 
information obtained from p87. The longest of these probes (based on 
the codon bias intbrmatlon i  [23]) was radioiabelled by addition of 
[~P]phosphate using T4 polynucl¢otide kinase, and used to screen a 
bovine brain eDNA library constructed in lambda ZAP 1I (Strut- 
agone ). Positive clones were purified by saecessive rounds of plaque 
purification, and eDNA inserts recovered by helper phage mediated 
excision. Both strands of each clone were then sequenced using the 
Sander didcoxy chain termination method (Sequenas¢, USB). 
2,3. Northern blot analysis 
Total RNA was isolated from frozen tissues using 8uanidinium 
isothioeyanate and centrifugation through a cushion of cesium chlo- 
ride. Total RNA O0 ms) was electrophoresed on a 1% agarose/formal- 
dehyde gel, transferred to nitrocellulose, hybridized with a NcoI frag- 
ment of the p87 eDNA (I x l06 cpm/ml) for IS h, washed (I x SSC 
55°C), and apposed to X-ray film with intensifying ~reens for 12 h 
at -70"C. 
2.4. Expression of p87 it= mammalian cell systems 
To express p87 in mammalian cells, the entire eDNA of 27B (see 
Fig. 2) was subeloned into pCMV4 (pCMV4-27B) and used to tran- 
siently tran~fect COS-7 cells (15 mg of plasmid per 15 em flask) using 
the DEAE-dextran method [9]. Transfection efficiency was controlled 
by simultaneous transfection ofCOS-7 ceils with a plasmid containing 
the D2 dopamin¢ receptor [6]. Permanent tranffection in L(tk-) cells 
was achieved by cotransfecting these cells with a plasmid encoding for 
resistance to the antibiotic G418 (pNEO) and pCMV4--27B (ratio 
1:20) using the calcium phosphate precipitation method, and then 
selecting for cells with G418 resistance (400 mg/ml). Cells demon trat- 
ing resistance to G418 were then selected clonally a d tested for the 
cxprassion of pCMV4-27B by Northern and Westent blot analysis. 
2.5. Cell culture and uptake assays 
Ltk- ceils were maintained in Dulbecco minimal essential medium 
supplemented with 10% heat inactivated fetal bovine serum and 0.1 
mg/ml gentamycin at 37~C in 5% COs, Positive expressing cells or 
controls were washed twice with phosphate buffered saline (PBS), 
incubated for 5-20 minutes at 37"C with PBS containing 0.1-1 mM 
of the radiolabelled substrate, washed 3 times with ice.cold PBS and 
then lysed with a solution of 0.1 N NaOH, 1% SDS. An aliquot of this 
seAution was then counted by liquid scintillation spectophotometry. 
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Fig. 1. Determination f peptide sequences for purified p87. (Inset) 
Autoradiogram of the purified material. A 1% aliquot of the prepara- 
tive purification material was removed and iodinatt.xt with 
[~:'~I]Bolton-Hunter reagent, d~alted on Sephadex G-50 to remove 
excess labelling reagent and then added back to the remainder of the 
unlabeled sample, concentrated onan Amicon YM-30 Centricon nit 
and then separated by 10% SDS-PAGE. The wet gel was then covered 
with plastic wrap and apposed to film at 4=C with two inteasil~in8 
screens for 2 h to produce the image shown. The autoradiogranl was 
then used as a guide to excise the appropriate bands. (Main figure) 
Chromatogram of the peptid¢ fragments ofp87 following CNBr cleav- 
age. The samples were separated by reverse-phase HPLC as described 
in Methods. The lower tracing (blank) was observed with solution 
alone whereas the middle tracing (¢untroi) represents when the non- 
protein containing blank sample was injected (processed identically to 
the protein containing sample). The upper tracing (sample) waq that 
obtained from the protein containing sample derived from the higher 
molecular weight band on the preparative SDS-polyacrylamide gel 
(inset). 
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3. KESULTS 
3.1. Purification a d protein microsequeneing of the p87 
protein 
The p87 protein was found to eopurify with the Dj 
dopamine receptor during its preparative-scale purifica- 
tion. Fig. 1 (inset) shows the autoradiogram obtained 
foUowing radioiodination and SDS-PAGE eleetropho- 
resis of the purified material. Two prominent proteins 
which have relative molecular weights of 68 and 87 kDa 
were observed. Based on the relative size of the protein, 
the 68 kDa protein (p68) was thought o be the D~ 
dopamine receptor. The identity of the 87 kDa protein 
(p87) was unknown. The p87 band was processed for 
amino acid sequence analysis by eleetroelution, dialysis, 
CNBr cleavage, and separation of peptides by micro- 
bore reverse phase HPLC (see Methods). The sequence 
of three of the peaks of p87 was obtained, and they 
neither corresponded to any sequence in available pro- 
tein databases nor bore homology with G-protein cou- 
pled receptors or guanine nueleotide binding proteins. 
3.2. Cloning of bovine and rat cDNAs for p87 from brain 
libraries 
A non-degenerate 54-base probe designed using the 
sequence of the longest peptide was radiolabelled, and 
used to detect positive clones in a bovine brain eDNA 
library by plaque hybridization. Screening of 1 x 10 ~ 
reeombinants yielded 54 positive clones. One of these 
clones, BT27B, was found to contain a long open read- 
ing frame of 2226 bases coding for a protein of 742 
amino acids (caled. MW = 82.5 kDa). Importantly, the 
long open reading frame contained the sequence of 
three of the p87 peptides, thus confirming the identity 
of this clone. Moreover, the calculated molecular weight 
of the BT27B clone (82,500 daltons) was in close agree- 
ment with the molecular weight of the p87 protein 
(-87,000 daltons) which was detected on SDS-PAGE by 
autoradiography. Using a probe from the bovine p87 
eDNA, the rat homologue of BT27B was isolated 
(KT10A) from a rat brain eDNA library (96 positive 
clones out of 1 × 10 ~ reeombinants) and sequenced. The 
rat and bovine p87 eDNAs were found to be highly 
conserved having 98.5% identity at the amino acid level. 
The nueleotide sequence for clone BT27B and the de- 
duced amino acid sequence of the rat and bovine open 
reading frames are shown in Fig. 2. In each ease the 
open reading frame is chosen to begin at the first Kozak 
consensus sequence which is in frame with the rest of the 
open reading frame and which is preceded by a termina- 
tion codon. 
3.3. Structural features of p87 protein 
The hydropathiciW profile of p87 dete..rmined using 
the algorithm of [21] suggests that p87 possesses 12 
hydrophobic domains which are of sufficient length to 
span a lipid bilayer. The location of the l~utative trans- 
membrane domains in the protein suggests that p87 
possesses a large hydrophilie amino-terminal domain, 
a short carboxyl-terminal domain, and two large hydro- 
philic loops between putative transmembrane (TM) seg- 
ments 6-7 and TM segments 7-8. The p87 sequence 
contains three possible sites for N-linked gly¢osylation 
(N-X-S/T) within the loop defined by the putative 7th 
and 8th TM segments (Ash 498, Asn s4n, Asn~7~). The se- 
quence of p87 also contained several potential sites of 
regulatory phosphorylation byprotein kinase A (Set 47, 
Thr ~7, and Thr 6~) and protein kinase C (Thr 2~, Ser 42, 
Ser 3s', Ser679), Interestingly, these consensus sites for 
regulatory phosphorylation are all found in domains 
which are predicted to be on the same side of the mem- 
brane bilayer and which, moreover, are on the opposite 
side of the membrane where the consensus sites for 
glyeosylation are found. Interestingly, two consensus 
sites for ATP binding motifs (GXGXXG(7-18an)K) are 
found in the sequence at aa129-143 lying in the amino- 
terminus near the putative TM1 and aa266-288 located 
in the region of putative TM4 and the loop between 
TM4 and TM5 [19]. A model for the possible transmem- 
brahe organization and the relative position of the var- 
ious sites of post-translational modifications are shown 
in Fig. 3a. 
3.4. Homologies of p87 sequence with known transport 
proteins 
Comparison of the p87 protein sequence with a data- 
base of protein sequence motifs reveals that p87 con- 
tains two amino acid 'signature' sequences which are 
conserved among proteins known to transport sugars 
and other nutrients across the plasma membrane of 
eukaryotie cells and bacteria [1,17] (see Fig. 3b legend). 
Moreover, when protein d~,tabanks were searched for 
homologies to p87, additional similarities were found 
with several members of the transporter protein family. 
Specifically, the best matches were found to be with the 
glucose transporters of rat, man and yeast (~26% iden- 
tit), over an --180 amino acid (AA) overlap), and the 
bacterial transporters for xylose (22% over 148 AA), 
arabinose (24% over 213 AA), citrate (24% over 176 
AA) and tetracycline (21% over 134 AA). In addition, 
significant homolog2¢ was also found with the rat so- 
dium channel (21% over 201 AA). This region of homol- 
ogy resides in the C-terminal half of the molecule. 
Several regions of striking homology between se- 
lected members of the transport family are shown in 
Fig. 3b. It is apparent that the more highly conserved 
regions bet.ween the different members of this class of 
protein are clustered to the same side of the membrane 
bilayer and occur primarily in the short hydrophilic 
loops conn0eting TM segments (i.e. A, B, A', and B') 
and the hydrophilie regions adjoining TM segments (i.e. 
C and C'). In addition, the alignment demonstrates that 
the amino-terminal half of these proteins is better con- 
served among different members than the earboxyl.ter- 
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minal half. Thi~ is evidenced by the large regions of 
conservation which extend well into the TM segments 
of regions A, B, and C. In contrast, the regions of 
conservation i the areas A', B', and C' are mostly 
limited to the short, putative extramembraneous re- 
gions. Fig. 3b also illustrates the presence of the trans- 
port protein signature sequences mentioned earlier. The 
first such motif, ([LIVMF]X[GLIVMFA]X[G]X8 
[LY]X.~[EQ]X6[ RK]), is found in region B and 
is perfectly conserved in p87 (LsGvGiGgsipivfsYfsE- 
flaqekR). Tite second motif, ([LIVMST][DE]X 
[LIVMFA]GR[RK]X4.sG), is represented in region A' 
and again this sequence is well conserved (although not 
perfectly) in p87 (LDkiGR1RmlaG) since the presence 
era Leu residue between the two Arc residues interrupts 
the motif. 
Another feature that p87 shares with these other 
transport proteins is a significant degree of internal ho- 
mology. This is evidenced by re!.~etition fcertain motifs 
in the regions A/A', B/B' and C/C'. In the regions de- 
fined by A and A' there is conservation of a sequence 
which connects TM segments 2 and 3 and 8 and 9 
(DRLGRR in A and DKIGRLR in A'). In regions B/B' 
the internal repeat follows the sequence EFLAQEKR 
in B and ELYPSDKR in B'. Fimdly, another internal 
repeat can be found in regions C/C' (PES in region C 
and PET in region C'). 
3.5. mRNA for p8 7 are found predom&antly in the cen- 
tral nervous system 
An mRNA (4--4.8 kb) could be detected for p87 in 
several species ncluding rat, bovine, and man (data not 
shown). Fig. 4 shows the results of Northern blot anal- 
ysis for the expression of p87 message in several regions 
of the rat CNS and periphery. In the CNS, a prominent 
message isdetected in the cortex, brain stem, hippocam- 
pus, and cerebellum. In contrast, no detectable message 
could be found in any of the peripheral tissues examined 
such as heart, liver, lung, kidney, spleen, or skeletal 
muscle. This analysis uggests that p87 is localized pre. 
dominantly tothe CNS. Moreover, the message appears 
to be widespread in its distribution within the CNS since 
it is found in roughly the same abundance in the four 
regions examined. 
3.6. Subcellui, r distribution of p87 
In order to determine the subcellular distribution of 
the p87 protein, a differential centrifugation technique 
[22] was used to generate a four fraction separation. In 
this fractioaation method the 'N' fraction is the nuclear 
fraction and a high concentration f lysozomes. The 'M' 
and 'L' fractions contain the heavy and light mitochon- 
dria respectively. These fractions also contain a high 
concentration of ss, naptosomes, and to a lesser degree 
plasma membrane, and lysozomes. The 'P' fraction con- 
tains the majority of the plasma membranes. Detection 
of the protein p87 was determined using an antipeptide 
antibody (MIL9) targeted towards a sequence in the 
large hydrophilic amino-terminal domain 
(RRSYSRFEEEDDDDFPAPA) of p87. Using MIL 9 
an immunoreactive band was detected at 85 kDa, and 
this labelling was blocked by simultaneous incubation 
of MIL 9 with an excess of the antigenic peptide (- and 
+ respectively). As can be seen in Fig. 5, The 'M' and 
'L' tractions contain, the majority of the p87 im- 
munoreaetivity with far less being detected in the nu- 
clear and plasma membrane fractions. This im- 
munoreactivity in the subcellalar fiactions corresponds 
in size to the imlaaunoreactive band observed in crude 
rat striatum homogenates. Interestingly, by immunohis- 
toehemistry the p87 signal is detected exclusively in neu- 
rons and localizes essentially with intracellular organ- 
elles (B. Guldhammer tel., data not shown). Thus, the 
distribution of p87 subcellularly is most consistent with 
a localization in synaptosomes/synaptic vesicles. Inter- 
estingly, no detectable immunreactive signal is seen in 
purified bovine adrenal ehromaffin vesicles, supporting 
the CNS specific nature of p87. 
3.7. Functional expression of the p87 proteh~ 
To determine the possible function of p87 in the CNS, 
p87 eDNA was expressed in both transient and stable 
fashion in COS-7 and L(tk-) ceils respectively. In these 
cells transport of several radiolabelled compounds in- 
eluding: dopamine, serotonin, norepinephrine, gluta- 
mate~ GABA: choline, 3-O-methyl glucose, 2-deoxyglu- 
cose, methylglucopyranoside, andmixtures of amino 
acids was not detected. In addition, no detectable in- 
creases in [aH]SCH23390 binding were observed. 
4. DISCUSSION 
4.1 P87 ix homologous to the family of nutrient trans- 
porters 
p87 is related to a class of proteins known to trans- 
port nutrients across the plasma membrane of mammal- 
ian, primitive ukaryotic (yeast, fungus, algae), and bac- 
terial cells (reviewed in [1]). This family of transport 
proteins hare several common features between them- 
selves and with p87. First, these proteins generally pos- 
sess 12 stretches of hydrophobic amino acids which very 
likely are membrane spanning segments [26]. The 
Fig, 2. Nuclcotide and peptide sequence of p87. Th~ nttcl¢otide se- 
quence of the bovine p87 (clone BT27B) is shown on the top line. The 
amino acid sequence is shown below. The deduced sequence of the rat 
p87 clone (RTI 0A) was found to by identical to the boviae amino acid 
sequence e~cept where noted (line below the bovine aa sequence). The 
underlined amino acid sequences correspond t  putative transmem- 
brahe domains predicted from hydropathicity analysis. The regions 
highlighted by asterisks indicate sequences which were found during 
peptide mierosequence analysis of theCNBr fragments of rat p87 
pro~.eiJi. 
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--433 ~AGTAGACP, CCG CTGCCGCCTGCCCCACTGCCGOGACCC CCGGCCTCACCCA~CCC T 
TATO TG G GG OACTCAG CCCAGATCTCCA~OACTCC TGG~AGAAGTAG~AGCCTTTTOTGAGTTATCC"~GOC~C~G~C~C~C~ 
O~T~T~OTT~CAGTA~TCT~TC~CTcTTC~TT~AATO~T~TOOG~T~O~O~T~C~ 
TAAACCC T~A~T0 OCCAGAT~ CTATATTCTATTC TGTGCCCAOAGTTAOTCAKACACA~"FfCAT~TAAGTAACTCGGGOAAGTG~C~TCOA 
COA00~(:TTOTG0~A~g'.TC~A~T~GG~GOGGOGA/~A'l"Z'CGOT~GTA~CC~GCC~CA~A~ O A GAG 00~ ~ AG~ GR.C CGO 
M g g G F R 
GCA GOT TTC AT(: COT COG GCC A~ GAC ATT GCC AAG GAA GTC RAG AAG 
A A F Z R G A K D Z A K B V K K 
CTG GAC AGA G'/~ CAG OAT G~A TAT TCC COG AGA TCC TAC TCC CG~ TTT 
L D R V Q D B Y S g R S T S R F 
CC~ GCC COT OCT OAT GGC TAT TAG CG¢ GG P" ORA OG P, G0¢ CJ~O OAT GAG 
P A P A D O Y ~ R G ~ G A Q D E 
ACC GAG GGC C~ SAC GAG CAT SAT GAG A~ TAC GAG GGG GAA TAT C~G 
T £ G {i D g D D E I T E G £ Y Q 
GGC GAG COG ATG GCA G~T Oc'G (;CA CC¢ CTG GeT GGA GTG AGO 0GO 
K G ~ R M A D G A P L A G V R G 
E 
0GO GGG COG GGA GAP, GCG C~ COG COG ARA C, AA CGG GAA GAA CTA GCC 
G G R G I.: A Q R R R B R ~ £ L A 
D 
T0G 0G0 CAT 0G~ C0C TTC CAG TOG ACA 0TO TAT TTC GTG CTT nOT CTG 
C G H G R F ~ H T L Y P v n ~ L 
TTC GTG GTG GG~ TTC GTG CTG CCC AGT OCT GAG A~ GAC ATG TGC CTG 
P V V G F V L n D A Z K D M C L 
C~ A~ GTC T~C G~G GGC AT(:; ~TG GTG 0GA GCC T~ C~ TOG GGA G~G 
h ~ v ~ L ~ 
TGT (~TG CTC ATC TCA CTC TCA 
C ~, & m s ~ s 
CTT TTC TCC COT CTC CTT TCT 
L F C R L n S 
CTG 0CA CAG GAG ~ COT GGG 
L A Q B K R G 
P-CT AT P- P, CC T~P. GCC ATC ATe 
n M A H A ~ I 
AGO OTC TT'I' OTC CTC OTC TOO 
R V F Y h v c 
COT TTC TTC CTG GAG AAT GGG 
R F r h R N O 
GCC AAG GGG CAT COT GAG CGA 
A K G II P E R 
ATC CAG TCT GAC ACA OGO GOO 
Z Q ~ D ¢ G A 
T 
AAT TTC CTC TOT TOT TTT GOT 
N P L S C P s 
TTC ~C TAC TAT GGC CTG ACT 
F P ~ 'f c n T 
ACC Atu~ GTG '~'L'C COT nGG G/~A 
T K "v .~" P S 
GGA CAG TAC TTC AAT GAC ~AG 
u ~ Y F N D K 
TOT TAT TTC CAG OAT GTC ACA 
C Y F E D V T 
ACT GAC CTG TTT ~AG TAC RAG 
T D L F g T 
CCC CTG GAC OTG ACG GOG ACG 
L D V T G T 
CTT COT GGG AAC ATT GTG TOT 
L P ~ N T v 
A '~ TCC TOT ~T~ Tee TOc '~TC 
L 
GGG ~,GG GTC AGO ATe GCA TCC 
O O V s I A S 
ACA GCC TTC GGC TTC CTG PAT 
T A F 9 P t N 
P 
G0A ATC ACC ~G OCT GCC COO 
O I T R A A p 
CCC GAG ACC COG GGG CAG GTG 
E T R G I~ V 
M Y ~ A ~ n w o c 
GTC AAC AGT GT¢ TTC OCt TTT TT~ T~A 
V N S V ~ A P P S 
GOG GTT ~GG ATC OGA GOG TCC ATe CCC 
C V G T G C~ S T p 
GAG CAT TTG AGC TOG CTC TGC ATG TTT 
tl L S W L C M P 
CCC ~AC TAT GGG TOG AGC TTT CAG ATG 
P li Y G H S P @ M 
GOT TTC COT TCT OTG TTT G~C ATT GOG 
A P P s v p A ~ C 
D R 
CAT GCA A~¢ ~AG ,%AO GTG GTG AP~ GO¢ 
fl A T K K V V N G 
A 
GAG GAG GAG GAC OAT CAT OAT GA¢ TTC 
E £ E D D D D D F 
Z 
GF..G GA~ O0C O~-C GCA TOT AGT ~AT GCC 
E E G O A @ S D A 
~-C ATe CCC COG GCA GAG TOT GGG GGC 
G Z ~ R A E S C C. 
0GO TTG GOT GAT GO"'- ~AG Gn'~ CCC CCG 
G L G D G E ~ D- P 
S 
CAG CAG TAT GAA GCC ATe CTA COG G;~G 
Q ~ B A Z L R Z 
T 
GCA CTG ATG GCC OAT GOT GTT GAG GTC 
h M n D O V B v 
I I  I t & l  Ik I 1 t I I  t i l  i I I i  ik tr 
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Fig. 3, Predicted transmembrane topography, post translational modifications and limited sequence alignment of p87. (A) Predicted post transla. 
tional modification sites and topological membrane organization of p87. Based on the hydropatltieity analysis of p87, the protein is expected to 
possess 12 TM segments which are indicated by the white rectangles. Tile membrane is indicated by the grey rectangle behind tile TM segments. 
The Imlypeptide backbone which connects these TM segments i indicated by the black lines. The squar~ and circles impos~l upon these lines 
aa~ G,9 ~ 42 ~7 Set ~ ). The branch-llke indicate the presence era consensus sites for protein kinase A and C respectively (Set 4 , Thr , Thr and Thr-, Ser , Set 3 ,
structures indicate the presence of consensus sites for N-linked glyeosylation (Ash "~:~, Asn ~,  Asn~73). (B) Alignment of selected regions of various 
transport proteins. The regions hown in these alignments correspond roughly to the hatched areas of the p87 model shown in Fig. 3a. These regions 
are labelled A, B, C, A', B', and C'. Residues that are conserved in the maj'ority of" the transporter proteins listed are printed in bold letters. Areas 
thought o reside in traasmembrane domains are bracketed by double broken lines. The transport proteins for which sequences are listed are: (1) 
p87, (2) the facilitated glucose transporter of rat (GIuGTR); (3) the insulin responsive human glucose transporter (IRGT); (4) the high affinity 
glucose transporter ofS. cerevtsiae (SNF3), (5) the galactose transporter o s, cerevL~lae (GAL2), (6) the xylose transport protein orE. coli CXYLE), 
(7) the arabinose transport promin of E, coli (ARAE), (8) the hexose-proton ¢otransporter of green algae (QUTD), (9) the quinatc transporter l" 
fungus (QAY'), (10) the glucose transport protein of blue-sreen algae (GLCP), (11) the lactose permeage of S. cerevistae (LACP), (12) maltose 
permcase gone from 5'. cerevi~iae (MAL6), (13) the citrate-proton symport of g. eoli (CIUI), (14) the probable transport p otein frozn leishmania 
(PROI). A consensus sequence isshown on the bottom li,~e of each cluster. Sequences for these transporter p oteins were obtained from the Swiss 
prat¢~n databank. 
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amino- and carboxyl-termini arc thought to lie on the 
same face of the membrane bilayer and in the case of 
the mammalian glucose transporter, this model of 
transmembrane topology has been tested and found to 
be consistent with experimental results [5,7,10,11]. 
Thus, based on the similarity of the hydropathicity of 
p87 with these other proteins, we have proposed a 
model of transmembrane organization (Fig. 3a) which 
places the amino and carboxy-termini of p87 on the 
'cytoplasmic' face of the membrane. This orientation 
places the large loop between putative TM 7 and 8 on 
the 'extracellular'/'ace of the membrane which is consis- 
tent with the presence of consensus ites for N-linked 
glycosylation i this domain. Similarly, this orientation 
also places all of the consensus substrate sites for regu- 
latory protein kinases on the putative cytoplasmic do- 
mains of the protein. The relative position of these po- 
tential sites of post-translational modification in p87 are 
summarized in Fig. 3a. 
The second feature which most of these proteins 
share is the presence of one or both of the so-called 
nutrient transporter 'signature' sequences which are 
well conserved in p87 and located in the eapected posi- 
tion (between TMs 4-5 and TMs 8-9). These signature 
sequences are highly specific and unlikely to be found 
by chance. The p87 protein also contains two versions 
of the well conserved 'RXGRR'  motif which is found 
in many members of this family and which is thought 
to form a b-turn connecting TMs 2 and 3 and TMs 8 
and 9 [1]. 
4.2. Does p87 fimction as a transporter? 
The homology which p87 shares with the family of 
nutrient ransporters suggests that p87 likely functions 
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Fig. 4. Northern blot analysis of p87 mRNA. In each of the lanes 30 
mg of total RNA from each of the indicated tissues was electrolahore- 
sed on a 1% agarose/formaldehyde gel, transferred tonitrocellulose, 
h)'bri=iz~d to a ra~,iolab~,l~, prou ,~ d~riv~,, from th~ c~din~ region of 
p87 eDNA. washed, and exposed to X-ray film for 24 h to obtain the 
autoradiogram shown. The arrows to the right-hand side of the au- 
toradiogram indicate the position of mRNA standards. 
I |1 I I  l i  n d~ J l  ~ I 
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Fig. 5. Sabccllular localization of I~7 immunoroactivity. Membrane 
fractions were prepared as descril~d [~], ¢l~)trophoro~l, blotted 
onto nitrocellulose and incubated with MIL9 antibody inthe presence 
(÷) and absence (-) of the antigenic peptide. The primary amibody 
was deteetecl by a ~condary anti-rabbit antibody conjugat~l with 
hor~radish l~roxida~ and diaminobenzidine. The :.rrow on the 
right-hand side indicates the imrnunoreaetive band which is blocked 
by peptide. See text for details of the composition feach fraction. 
as a transport protein in the CNS. Thus, the obvious 
question which remains to be answered is the nature of 
the substrate for p87. It seemed likely that given the 
rather specific localization of p87 to the brain, the sub- 
strate would likely be a compound which is found pre- 
dominantly in the CNS. However, it is now known that 
the Na + and Cl- dependent plasma membrane transport 
proteins for compounds uch as the neurotransmitters 
(e.g. GABA, NE, DA and 5-HT) bear little or no se- 
quence homology to p87 (reviewed in [32]). Thus, not 
unexpectedly, expression studies in mammalian cells of 
p87 failed to show any accumulation across the plasma 
membrane of several major neurotransmitter com- 
pounds (data not shown). The strong homology which 
p87 shows to the proton-driven bacterial transporter 
family suggests that the substrate would likely be a 
'nutrient.' However, the only sugar utilized by the brain 
for metabolism is glucose, and glucose transport pro- 
teins have already been identified in the brain [3,17]. 
Moreover, we have failed to detect he plasma mem- 
brane transport of a variety of carbohydrates in cells 
transfected (transiently and permanently) with p87. In 
addition, p87 does not appear to transport amino acid 
substrates such as glutamate, aspartate, glycine, GABA 
(data not shown). 
Another possibility for the apparent lack of detecta- 
ble transport activity for p87 might be that the protein 
is directed to another cellular organelle than the plasma 
membrane. Several properties of p87 are consi:stent with 
this hypothesis. First, given the neuronal specificity of 
p87, it might be expected to subserve a function com- 
mon to neurons but not all cells. One of the intracellular 
specializations unique to neurons is the synaptic vesicle. 
Although not conclusive in this respec:, the subeellular 
distribution of p87 presented here (Fig. 5) is consistent 
with this possibility. Second, a vesicular location of p87 
would fit with its structural homology with the bacterial 
transporters which like vesicular transporters are often 
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proton.driven (Stern-Bach et al., 1990). In addition, the 
widespread distribution of' p87 is not consistent with 
any one single neurotransmitter system in the brain and 
would suggest he p87 substrate could well be a com- 
mon constituent of several types of synaptic vesicles. It 
is tempting to speculate, given the presence of two con- 
sensus ATP binding sites in this protein, that p87 could 
play a role in the transport ot'ATP or protons which are 
found in many types of synaptie vesicles. A transporter 
for ATP might be expected to display some specificity 
for sugar residues (e.g. ribose), thus the similarity of p87 
with sugar transporters. Obviously, this possibility re- 
mains to be thoroughly tested. The difficulty in testing 
such a hypothesis has been the development of suitable 
assay systems. 
Thus, in this report we describe a new CNS specific 
protein which appears to define a new transporter fam- 
ily. Thusfar the basis for the eopurifieation of p87 with 
the D~ dopamine receptor is still not understood. How- 
ever, the further characterization of this novel protein 
using the tools (eDNA probes, cell lines, antibodies, etc, 
which have been developed should eventually lead to a 
more complete understanding of the functional role of 
p87 in the brain. Further work may likely reveal other 
members of this family of proteins and provide new 
insights into brain function. 
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Note added in proof 
The eDNA and protein sequences for rat p87 reported in this paper are virtually identical to the sequences reported 
recently for rat synaptic vesicle protein 2 (SV2), a membrane glycoprotein localized to secretory vesicles (Bajjalieh, 
$.M., Peterson, K., Shinghai, R. arid Scheller, R.H., Science 257, 1271--1273, 1992; Feany, M.B., Lee, S., Edwards, 
R.H. and Buek!ey, K.M., Cell 70, 861-867, 1992). 
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